Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
From Twitter To Treatment Guidelines, Industry Influence Permeates Medicine

The long arm of the pharmaceutical industry continues to pervade practically every area of medicine, reaching those who write guidelines that shape doctors' practices, patient advocacy organizations, letter writers to the Centers for Disease Control and Prevention and even oncologists on Twitter, according to a series of papers on money and influence published Tuesday in JAMA Internal Medicine.

Published
18 January 2017
From
NPR
Turning “off” these 3 genes would protect T cells from HIV

A team of researchers at the Ragon Institute of MGH, MIT and Harvard and the Broad Institute of MIT And Harvard have recently identified human genes that could be the key to a gene therapy-based HIV treatment.

Published
17 January 2017
From
BETA blog
SA can save billions with new HIV drug combination

The ADVANCE study will evaluate an HIV treatment regimen including two newer and cheaper drugs: dolutegravir (DTG) and tenofovir alafenamide (TAF).

Published
17 January 2017
From
Health24
Converging Roads Between HIV and Cancer Research

In 2017, a key focus in the field of HIV will be investigating new ways to tackle persistence via interactions and synergies with other fields such as cancer research and immune-based therapies. This will take centre stage when the scientific community convenes in July 2017 at the IAS HIV Cure & Cancer Forum and the 9th IAS Conference on HIV Science (IAS 2017).

Published
16 January 2017
From
International AIDS Society
Worried About HIV and Aging? The First Thing to Do Is Stop Smoking

There are people out there who are anxious about the impact HIV has on the aging process, but who continue to smoke. This is to be preoccupied by a threat that we don't quite understand and are not sure how to deal with, while neglecting a very real health threat that can be changed and brought under control.

Published
12 January 2017
From
The Body
London doctors on verge of defeating HIV thanks to new programme

London doctors believe they could be on course to defeat HIV after a dramatic fall in the number of new infections, the Standard can reveal. An early intervention programme imported from San Francisco has seen a 42 per cent reduction in new cases of HIV at 56 Dean Street in Soho, the biggest sexual health clinic in Europe.

Published
11 January 2017
From
London Evening Standard
Gilead Awards More Than $22 Million in Grants to Support HIV Cure Research

Gilead Sciences, Inc. today announced the recipients of its HIV cure grants program, a fund totaling more than $22 million, which will support 12 new HIV cure research projects. These projects will be conducted by leading academic institutions, non-profit organizations and community groups from around the world, focusing on three key areas: translational research, efficacy studies in animal models and community perspectives of HIV cure.

Published
10 January 2017
From
Gilead press release
The Success Of HIV Treatment Is Increasing The Risk Of Drug-Resistance

Global health agencies are succeeding in getting more people with HIV on antiretroviral therapy, a combination of drugs that suppress the virus to undetectable levels in the blood and reduce the risk of transmission to another person. But scientists are beginning to detect a disturbing new trend: The rise of drug-resistant HIV strains, especially in countries such as Kenya, Zambia, Uganda, Nigeria, Tanzania and South Africa.

Published
04 January 2017
From
Huffington Post
Gates Foundation to Invest Up to $140 Million in HIV Prevention Device

The tiny implantable drug pump is being developed by Intarcia Therapeutics Inc. It can hold six or 12 months’ supply of medicine and is designed to deliver microdoses continuously to patients, ensuring they stay on the treatment.

Published
30 December 2016
From
Wall Street Journal
Virologic failure detected in a quarter of ART-treated children in Tanzania

A quarter of children and adolescents in Tanzania taking antiretroviral therapy (ART) have major resistance to one or more anti-HIV drug, investigators report in AIDS. In 86%

Published
28 December 2016
By
Michael Carter
← First12345...433Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.